People suffering from chronic diseases may become a real burden for their relatives and society in general. What is even worse is that the percentage of such cases is increasing each year and some chronic diseases can lead to tough health state complications and death. That’s why it’s important to know major information about these illnesses to be ready to face reality and be able to set short-term goals to maintain the current state, avoid, or mitigate the illness’s progress.
With the proper chronic disease treatment and emotional support that is a source of great help, we do our best to assist patients to avoid feeling helpless and out of control over the situation and their health condition. So, nanomedicines are the only effective way to resolve this issue: the correctly defined diagnosis is an important part of the research area to increase patients’ survival rate and make them full members of society.
Nowadays scientists strive to find reliable methods to cure patients with chronic diseases by digging deeply into precision medicine and using revolutionizing technologies. Nanotechnology has been developing greatly to diagnose, treat, and mitigate chronic illnesses. To improve patients’ health conditions or at least keep them unchanged and stable, biotechnology engineers and scientists hope to identify strong drugs that will be targeted directly to the symptoms and elimination of the chronic disease, define biomarkers to outline the main features of a particular illness state, etc.
Cardiovascular diseases, Alzheimer’s, chronic lung disease, cancer, epilepsy, etc are the world’s most known and widespread chronic illnesses that cause death among adults who suffer from two or more diseases at the same time. The rapid growth of those illnesses made medicine-related experts, public health care workers, and scientists work on effective new treatments and check-ups to prevent severe consequences.
Let us show the situation with Alzheimer’s disease treatment: AD is the major form of dementia that is around 70% of all cases, and it’s expected to gain 130 million by 2050, there’s an urgent need to apply advanced technology to treat this illness. For example, recently discovered biomarkers like proteins NfL, neurogranin, and Tau help to identify AD at its early stages and monitor its progression. Also, state-of-the-art nanomedicine approaches like polymeric, lipid, and metal-based nanoparticles are useful in drugs’ effective transporting to the brain that increase the efficiency of AD treatment with new compounds.
Such an advanced AD treatment with nanoparticles results in the effective delivery of bioactive molecules to the brain cells and better protection from harmful chemicals. Nanoparticles are capable of bringing molecules to hardly accessible tissues and cross the protective mechanism of BBB.
What about diabetes treatment, nanotechnology also plays a crucial role in efficient disease monitoring and selection of fitting therapy. Specific advanced tools are used to design continuous glucose monitoring sensors that can be implanted under the skin to track glucose levels in real time. Scientists implement nanoparticles to diagnose type 1 diabetes at its early stages and create more effective vaccines for it. Moreover, there are glucose-responsive nanoparticles that imitate the physiological needs for insulin.
To summarize, implementing diverse nano-based technology for the treatment for chronic diseases continues to gather momentum and facilitates more effective supporting therapy measures to mitigate patients’ health state and make their lives full and bright.